Atlas Trials

Follow-up of the EPITOPE Study to Evaluate Long-term Efficacy and Safety of DBV712 in Young Children

Clinical trial NCT03859700 · COMPLETED

Trial details

NCT number
NCT03859700
Sponsor
DBV Technologies
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Peanut Allergy
Start date
2018-12-06
Primary completion
2025-05-13
Enrollment
304

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.